Patients
Physicians
Sponsors
Oncologists
About Us
News
ENG
Last updated 16 days ago
Share
Lunsayil 1: A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Hidradenitis Suppurativa
200 patients around the world
Available in
Spain, United States, Argentina
Main endpoints for Part 2 will be supported by Part 1 results available at time of primary analysis.
Boehringer Ingelheim
4
Research sites
200
Patients around the world
This study is for people with
Hidradenitis suppurativa
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Inclusion criteria
Exclusion criteria
Sites
Centro de Investigaciones Médicas Mar del Plata SRL
Recruiting
View site
Av. Colón 3083, Mar del Plata, Buenos Aires
Centro de Investigaciones Médicas Mar del Plata SRL
Recruiting
View site
Av. Colón 3083, Mar del Plata, Buenos Aires
Hospital Santa Creu i Sant Pau
Recruiting
View site
C/ de Sant Quintí, 77, 08041 Barcelona, Spain
Hospital Santa Creu i Sant Pau
Recruiting
View site
C/ de Sant Quintí, 77, 08041 Barcelona, Spain
Hospital Universitario Reina Sofía
Recruiting
View site
14004 Córdoba, Spain
Hospital Universitario Reina Sofía
Recruiting
View site
14004 Córdoba, Spain
Hospital Universitario San Cecilio
Recruiting
View site
Av. del Conocimiento, Granada, Spain
Hospital Universitario San Cecilio
Recruiting
View site
Av. del Conocimiento, Granada, Spain
See details
Contact us
Contact us
Sponsor
Boehringer Ingelheim
Conditions
Requirements
From 18 Years
All Gender
Unique study ID
clinicaltrials.gov
NCT05819398
About us
Our mission
Our team
Partners
FAQs
Medical news
Latest news
Studies
Interviews
Testimonials
Products
UEPM Onco
UEPM Physicians
Links
Downloads
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent